共 50 条
- [3] 18F-DCFPyL PET/CT in Newly Diagnosed Prostate Cancer: Diagnostic Value of Intraprostatic PSMA Uptake in Risk Classification of Prostate Cancer [J]. FRONTIERS IN ONCOLOGY, 2022, 12
- [6] 68Ga-PSMA PET/CT Staging of Newly Diagnosed Intermediate- and High-Risk Prostate Cancer [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2019, 21 (02): : 100 - 104
- [7] AMONG MEN WITH GLEASON GRADE GROUP 3, INTERMEDIATE-RISK PROSTATE CANCER, STAGE CT2 IS ASSOCIATED WITH METASTATIC RECURRENCE [J]. JOURNAL OF UROLOGY, 2019, 201 (04): : E958 - E959
- [8] Variability in Outcomes for Patients with Intermediate-risk Prostate Cancer (Gleason Score 7, International Society of Urological Pathology Gleason Group 2-3) and Implications for Risk Stratification: A Systematic Review [J]. EUROPEAN UROLOGY FOCUS, 2017, 3 (4-5): : 487 - 497
- [9] Risk Factors of Patients with Prostate Cancer Upgrading for International Society of Urological Pathology Grade Group 1 After Radical Prostatectomy [J]. UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2022, 21 (01): : 10 - 13